about
The role of matrix in HIV-1 envelope glycoprotein incorporationA comparative analysis of the fluorescence properties of the wild-type and active site mutants of the hepatitis C virus autoprotease NS2-3Biochemistry and cell biology of mammalian scavenger receptors.Identification using phage display of peptides promoting targeting and internalization into HPV-transformed cell lines.Exposing HIV's weaknessesEnhanced hepatitis C virus genome replication and lipid accumulation mediated by inhibition of AMP-activated protein kinaseThe subcellular localization of the hepatitis C virus non-structural protein NS2 is regulated by an ion channel-independent function of the p7 proteinHepatitis C virus-induced autophagy is independent of the unfolded protein response.Biochemical evidence of a role for matrix trimerization in HIV-1 envelope glycoprotein incorporation.Structural and Molecular Determinants of Membrane Binding by the HIV-1 Matrix Protein.Elucidating the mechanism by which compensatory mutations rescue an HIV-1 matrix mutant defective for gag membrane targeting and envelope glycoprotein incorporation.Trimer Enhancement Mutation Effects on HIV-1 Matrix Protein Binding Activities.Global rescue of defects in HIV-1 envelope glycoprotein incorporation: implications for matrix structure.The cytoplasmic tail of retroviral envelope glycoproteins.HIV-1 gag: an emerging target for antiretroviral therapy.The Use of Minimal RNA Toeholds to Trigger the Activation of Multiple Functionalities.LOX-1 scavenger receptor mediates calcium-dependent recognition of phosphatidylserine and apoptotic cells.Characterisation of the role of zinc in the hepatitis C virus NS2/3 auto-cleavage and NS3 protease activities.Hepatitis C VirusVisualization of HIV-1 RNA Transcription from Integrated HIV-1 DNA in Reactivated Latently Infected CellsHIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein IncorporationVisualization of Positive and Negative Sense Viral RNA for Probing the Mechanism of Direct-Acting Antivirals against Hepatitis C VirusEffects of Moloney Leukemia Virus 10 Protein on Hepatitis B Virus Infection and Viral ReplicationToward Structurally Novel and Metabolically Stable HIV-1 Capsid-Targeting Small MoleculesAnalysis of HIV-1 Matrix-Envelope Cytoplasmic Tail Interactions
P50
Q27023106-A3F3CF1D-85BB-4CE5-B502-BCE80D941010Q27490941-4E37E714-11E7-44FC-ADBB-8CC17CF22C7EQ30350741-3E815992-5C5E-4B3A-9013-C776C4278AA0Q31114638-F35DD979-108F-4C13-A580-1EFCF0EEA443Q33567645-1D30BFA7-3D67-4063-9E9E-3BDA4BFDEA01Q33953064-1EFF2956-042E-40A8-9B3A-F6AE9F6A59A1Q35097566-95130DD3-2A72-429C-99BC-CD77CEC192A9Q36276577-B85895D1-8786-418E-93A9-D49B897B37EDQ36483275-4C1D2666-EEEA-4AC9-B48D-52D5C990A914Q36812591-0554036B-72F4-4035-97A9-0C5305D7D13FQ36833301-C4865936-8F42-40DE-9D1D-CA34C48C1994Q36950860-979DEE45-12FF-4181-B862-C59A2C97D08CQ37308716-D1BB6ED8-588E-42E8-A97C-E7A05D703874Q38321444-F0D545BD-6326-463B-BA9E-4F267DB06414Q38366763-B2397096-44C0-4525-B84E-229B0F997104Q38790180-9C492F63-7D38-48FC-81E2-C2E974A2E57AQ40376526-EAC3F7C8-809A-49D7-B03E-0100CE4EFBC1Q43035256-D51EAC57-3971-49C5-B2C8-0F7F1B5671DBQ56333534-7DF7794B-BA20-4523-A93C-3CE8653D766DQ57064408-2386414D-D734-43BE-AE90-59E3CF0E4FF1Q90753657-474D1AA0-0485-4EE8-84B4-7A35AECC4F1FQ91252109-A398B4BB-9F0B-42EE-8801-629BE56A9EB9Q91993592-AF8CD070-DAD6-4F29-BB3F-91F1C4FE6F17Q92121372-2B3DBB59-CD27-4F08-9C83-6730EFFFBC69Q92376560-8395DF49-5558-48EB-8218-91826BC4B4A7
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Philip Tedbury
@ast
Philip Tedbury
@en
Philip Tedbury
@es
Philip Tedbury
@nl
Philip Tedbury
@sl
type
label
Philip Tedbury
@ast
Philip Tedbury
@en
Philip Tedbury
@es
Philip Tedbury
@nl
Philip Tedbury
@sl
prefLabel
Philip Tedbury
@ast
Philip Tedbury
@en
Philip Tedbury
@es
Philip Tedbury
@nl
Philip Tedbury
@sl
P106
P1153
8677822100
P21
P31
P496
0000-0001-8151-4967